in this population compared to patients who are bDMARD-and tsDMARD-naive. A minimal initial treatment goal of low disease activity is conditionally recommended over a goal of remission An initial target of low disease activity is preferred because remission by established criteria may not be achievable for many patients Modification of DMARD(s) Addition of a bDMARD or tsDMARD is conditionally recommended over triple therapy (i.e., addition of sulfasalazine and hydroxychloroquine) for patients